M. T. Vu Hai

M. T. Vu Hai's work focuses on pharmacokinetic and pharmacodynamic (PK/PD) modeling, which studies how drugs move through the body and how they produce their effects, to help predict and optimize drug dosing. Recent projects involve translating findings from lab/animal studies to first-in-human clinical trials for novel cancer drugs, modeling drug clearance and dosing in special populations such as older adults, and evaluating therapeutic drug monitoring approaches. This research supports the design of clinical trials and personalized dosing strategies across areas including oncology, cardiology, and transplant medicine.

Publication activity was minimal or absent for most of the past decade but increased sharply starting in 2023, with a noticeable rise in output through 2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026